BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 22027594)

  • 1. Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-therapy and multimodal imaging.
    Ma M; Chen H; Chen Y; Wang X; Chen F; Cui X; Shi J
    Biomaterials; 2012 Jan; 33(3):989-98. PubMed ID: 22027594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.
    Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J
    ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
    Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
    Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimuli-responsive nanocomposites for magnetic targeting synergistic multimodal therapy and T
    Chen Y; Deng X; Li C; He F; Liu B; Hou Z; Cheng Z; Xing B; Lin J
    Nanomedicine; 2017 Apr; 13(3):875-883. PubMed ID: 27993724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A photoresponsive and rod-shape nanocarrier: Single wavelength of light triggered photothermal and photodynamic therapy based on AuNRs-capped & Ce6-doped mesoporous silica nanorods.
    Sun Q; You Q; Pang X; Tan X; Wang J; Liu L; Guo F; Tan F; Li N
    Biomaterials; 2017 Apr; 122():188-200. PubMed ID: 28131043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
    Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
    J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
    Tran VA; Vo VG; Shim K; Lee SW; An SSA
    Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional hybrid materials for combined photo and chemotherapy of cancer.
    Botella P; Ortega I; Quesada M; Madrigal RF; Muniesa C; Fimia A; Fernández E; Corma A
    Dalton Trans; 2012 Aug; 41(31):9286-96. PubMed ID: 22555652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
    Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
    Small; 2017 Jan; 13(2):. PubMed ID: 27735129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy.
    Huang P; Bao L; Zhang C; Lin J; Luo T; Yang D; He M; Li Z; Gao G; Gao B; Fu S; Cui D
    Biomaterials; 2011 Dec; 32(36):9796-809. PubMed ID: 21917309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy.
    Monem AS; Elbialy N; Mohamed N
    Int J Pharm; 2014 Aug; 470(1-2):1-7. PubMed ID: 24792973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional uniform core-shell Fe3O4@mSiO2 mesoporous nanoparticles for bimodal imaging and photothermal therapy.
    Li J; Jiang H; Yu Z; Xia H; Zou G; Zhang Q; Yu Y
    Chem Asian J; 2013 Feb; 8(2):385-91. PubMed ID: 23225542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
    Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
    Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated graphene oxide-capped gold nanorods/silica nanoparticles as multifunctional drug delivery platform with enhanced near-infrared responsiveness.
    Qi Z; Shi J; Zhang Z; Cao Y; Li J; Cao S
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109889. PubMed ID: 31499943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
    Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient near-IR hyperthermia and intense nonlinear optical imaging contrast on the gold nanorod-in-shell nanostructures.
    Hu KW; Liu TM; Chung KY; Huang KS; Hsieh CT; Sun CK; Yeh CS
    J Am Chem Soc; 2009 Oct; 131(40):14186-7. PubMed ID: 19772320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Assembled Upconversion Nanoparticle Clusters for NIR-controlled Drug Release and Synergistic Therapy after Conjugation with Gold Nanoparticles.
    Cai H; Shen T; Kirillov AM; Zhang Y; Shan C; Li X; Liu W; Tang Y
    Inorg Chem; 2017 May; 56(9):5295-5304. PubMed ID: 28402112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of mesoporous silica-encapsulated gold nanorods as enhanced light scattering probes for cancer cell imaging.
    Zhan Q; Qian J; Li X; He S
    Nanotechnology; 2010 Feb; 21(5):055704. PubMed ID: 20023304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined chemo/photothermal therapy based on mesoporous silica-Au core-shell nanoparticles for hepatocellular carcinoma treatment.
    Wang J; Zhang Y; Liu L; Cui Z; Liu X; Wang L; Li Y; Li Q
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1487-1495. PubMed ID: 31172835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.